FIELD OF THE INVENTION
[0001] The present Invention relates to a liquid composition, comprising a subtilisin and
a subtilisin stabilizer.
BACKGROUND OF THE INVENTION
[0002] Storage stability problems are well known with liquids containing enzyme(s). Especially
in enzyme-containing liquid detergents a major problem, in particular If the detergent
contains protease, is that of ensuring enzyme activity over time
The prior art has dealt extensively with improving the storage stability, for example
by adding a protease inhibitor.
Bone acid and boronic acids are known to reversibly inhibit proteolytic enzymes. A
discussion of the inhibition of one serine protease, subtilisin, by boronic acid is
provided in
Molecular & Cellular Biochemistry 51, 1983, pp. 5-32.
Boronic acids have very different capacities as subtilisin inhibitors. Boronic acids
containing only alkyl groups such as methyl, butyl or 2-cyclohexylethyl are poor inhibitors
with methylboronic acid as the poorest inhibitor, whereas boronic acids bearing aromatic
groups such as phenyl, 4-methoxyphenyl or 3,5-dichlorophenyl are good inhibitors with
3,5-dichlorophenylboronic acid as a particularly effective one (see
Keller et al, Biochem. Biophys. Res. Com. 176, 1991, pp 401-405).
It is also claimed that aryl boronic acids which have a substitution at the 3-position
relative to boron are unexpectedly good reversible protease Inhibitors. Especially,
acetamidophenyl boronic acid is claimed to be a superior inhibitor of proteolytic
enzymes (see WHO 92/19707)
In
WO 96/41859 substituted phenyl boronic acids are disclosed as suitable enzyme stabllizers.
It has been found that borates are reprotoxic in animals and therefore there is a
demand to find alternatives which can be used to stabilize the enzymes in liquid compositions.
In a particular embodiment of the present invention the liquid composition does not
comprise borate or boric acid
In
EP 0 378 261 B1 an enzyme stabilization system comprising carboxylic acids for aqueous liquid detergent
compositions is disclosed.
[0003] US 5 919 313 A discloses a contact lens cleaning composition comprising an enzyme, an aromatic acid
derivative and optionally surfactants. The aromatic acid derivative can be for instance
benzoic acid, phenylacetic acid, phenylpropionic acid or phenylbutyric acid.
SUMMARY OF THE INVENTION
[0004] One object of the present invention is to provide a stable liquid composition.
It has surprisingly been found that certain aryl carboxylic acids have extraordinary
good capacities as subtilisin stabilizers in liquids, especially the stabilizers indicated
below.
[0005] The present invention provides thus a liquid composition comprising a subtilisin
and a subtilisin stabilizer as described below.
DETAILED DESCRIPTION OF THE INVENTION
The stabilizer
[0006] The present invention relates to stabilization of subtilisins in liquid compositions.
The present invention provides a liquid composition comprising a subtilisin and a
subtilisin stabilizer which is:
3-chlorobenzoic acid, 4-chlorobenzoic acid, 3,5-dichlorobenzoic acid, 3-chlorophenylacetic
acid 3-chlorophehyl-3-propionic acid, and their corresponding salts
[0007] In a particular embodiment of the present invention the liquid composition comprises
0.001-20% w/w of the stabilizer. In a more particular embodiment of the present invention
the liquid composition comprises 0.01-15% of the stabilizer. In an even more particular
embodiment of the present invention the liquid composition comprises 0.1-10% w/w of
the stabilizer. In a most particular embodiment of the present invention the liquid
composition comprises 0.5-5 % of the stabilizer. In a further particular embodiment
of the present invention the liquid composition comprises 1.5 to 5% w/w of the stabilizer.
In a particular embodiment of the present invention the liquid composition comprises
0.05-1000 mM of the stabilizer. In a more particular embodiment of the present invention
the liquid composition comprises 0.5-750 mM of the stabilizer. In an even more particular
embodiment of the present invention the liquid composition comprises 5-500 mM of the
stabilizer. In a most particular embodiment of the present invention the liquid composition,
comprises 25-250 mM of the stabilizer
In a particular embodiment the present invention provides a liquid detergent composition
comprising a surfactant, a subtilisin and a subtilisin stabilizer of any of the formulas
disclosed above.
[0008] It has surprisingly been found that the stabilizer also have a stabilizing effect
at pH above 8 such as above 9.
Active compounds
[0009] According to the invention the liquid composition contains at least one subtilisin
Mixtures of subtilisins are also included.
[0010] In a particular embodiment the liquid composition comprises more than 2 different
enzymes. In a particular embodiment a liquid composition comprising two or more enzymes
in which the first enzyme is a subtilisin and the second enzyme is selected from the
group consisting of amylases, lipases, cellulases, lyases and oxidoreductases is preferred.
In a more particular embodiment the second enzyme is a lipase.
[0011] It Is to be understood that subtilisin variants (produced, for example, by recombinant
techniques) are included within the meaning of the term subtilisin. Examples of such
subtilisin variants are disclosed, e.g. in
EP 251,446 (Genencor),
WO 91/00345 (Novozymes),
EP 525,610 (Solvay) and
WO 94/02616 (Gist-Brocades NV).
[0012] Subtilisins are well-characterized physically and chemically. In addition to knowledge
of the primary structure (amino add sequence) of these enzymes, over 50 high resolution
X-ray structures of subtilisins have been determined which delineate the binding of
substrate, transition state, products, at least three different protease inhibitors,
and,define the structural consequences for natural variation (
Kraut (1977) Ann. Rev. Biochem. 46 331-358).
One subgroup of the subtilases, I-SI, comprises the "classical" subtilisins, such
as subtilisin 168, subtilisin BPN', subtilisin Carlsberg (ALCALASE®, Novozymes A/S),
and subtilisin DY.
A further subgroup of the subtilases I-S2, is recognised by Siezen et al. (supra).
Sub-group IS2 proteases are described as highly alkaline subtilisins and comprise
enzymes such as subtilisin PB92 (MAXACAL®, Gist-Brocades NV), subtilisin 309 (SAVINASE®,
Novozymes A/S), subtilisin 147 (ESPERASE®, Novozymes A/S), and alkaline elastase YaB.
Random and site-directed mutations of the subtilase gene have both arisen from knowledge
of the physical and chemical properties of the enzyme and contributed information
relating to subtilase's catalytic activity, substrate specificity, tertiary structure,
etc (
Wells et al. (1987) Proc. Natl. Acad. Sci. U.S.A. 84; 1219-1223;
Wells et al. (1986) Phil. Trans. R. Soc. Lond.A. 317 415-423;
Hwang and Warshel (1987) Biochem. 26 2669-2673;
Rao et al., (1987) Nature 328 551-554.
More recent publications covering this area are
Carter et al. (1989) Proteins 6240-248 relating to design of variants that cleave a specific target sequence in a substrate
(positions 24 and 64);
Graycar et al. (1992) Annals of the New York Academy of Sciences 672 71-79 discussing a number of previously published results; and
Takagi (1993) Int. J. Biochem. 25 307-312 also reviewing previous results.
[0013] Examples of commercially available subtilisins include Kannase™, Evertase™, Esperase™,
Alcalase™, Durazym™, Savinase™, Ovozyme™, Pyrase™, and Clear-Lens™ Pro (all available
from Novozymes A/S, Bagsvaerd, Denmark). Other preferred include those described in
WO 01/58275.
Other commercially available subtilisins include Maxatase™, Maxacal™, Maxapem™, Opticlean™,
Propease™, Purafect™ and Purafect Ox™ (available from Genencor International Inc.,
Gist-Brocades, BASF, or DSM Nutritional Products).
[0014] Lipases: Suitable lipases include those of bacterial or fungal origin Chemically
or genetically modified mutants are included.
Examples of useful lipases include a Humicola lanugi-nosa lipase, e.g., as described
in
EP 258 068 and
EP 305 216, a Rhizomucor miehei lipase, e.g., as described in
EP 238 023, a Candida lipase, such as a C. antarctica lipase, e.g., the C antarctica lipase
A or B described in
EP 214 761, a Pseu-domonas lipase such as a P. pseudoalcaligenes and P. alcali-genes lipase,
e.g , as described in
EP 218 272, a P. cepacia lipase, e g , as described In
EP 331 376, a P. stutzeri li-pase, e.g., as disclosed in
BP 1 372,034, a P. fluorescens lipase, a Bacillus lipase, eg., a B subtilis lipase (
Dar-tols et al., (1993), Biochemica et Biophysica acta 1131, 253-260), a B. stearothermophilus lipase (
JP 64/744992) and a B. pumilus lipase (
WO 91/16422).
Furthermore, a number of cloned lipases may be useful, including the Penicillium camenbertii
lipase described by
Ya-maguchi et al., (1991), Gene 103, 61-67), the Geotricum can-didum lipase (
Schimada, Y. et al., (1989), J. Biochem 106, 383-388), and various Rhizopus lipases much as a R. delemar lipase (
Hass, M.J et al., (1991), Gene 109, 117-113), a R niveus lipase (
Kugimiya et al., (1992), Biosci. Biotech. Bio-chem. 56, 716-719) and a R. oryzae lipase.
Other types of lipolytic enzymes such as culinases may also be useful, e g., a cutinase
derived from Pseudomonas mendocina as described in WHO 88/09367, or a culinase derived
from Fusarium solani pisi (e.g. described in
WO 90/09446).
Examples of commercially available lipases include Lipex™, Lipoprime™, Lipopan™, Lipolase™,
Lipolase™ Ultra, Lipozyme™, Palatase™, Resinase™, Novozym™ 435 and Lecitase™ (all
available from Novozymes A/S).
Other commercially available lipases include Lumafast™ (
Pseudomonas mendocina lipase from Genencor International Inc.), Lipomax™ (
Ps pseudoalcaligenes lipase from Gist Brocades/Genencor Int. Inc ; and
Bacillus sp. lipase from Solvay enzymes. Further lipases are available from other suppliers
such as Lipase P "Amano" (Amano Pharmaceutical Co. Ltd.).
Amylases. Suitable amylases (α and/or ß) include those of bacterial or fungal origin.
Chemically or genetically modified mutants are included. Amylases include, for example,
a-amylases obtained from a special strain of B. licheniformis, described in more detail
in British Patent Specification No.
1,296,839 Commercially available amylases are Duramyl™, Termamyl™, Fungamyl™ and BAN™ (available
from Novozymes A/S) and Rapidase™ and Maxamyl P™(available from Gist-Brocades).
Cellulases: Suitable cellulases include those of bacterial or fungal origin Chemically
or genetically modified mu-tants are included. Suitable cellulases are disclosed in
US 4,435,307, which discloses fungal cellulases produced from Humicola insolens Especially suitable
cellulases are the cellulases having color care benefits. Examples of such cellulases
are cellulases described in European patent application No.
0 495 257.
Oxidoreductases: Any oxidoreductase suitable for use in a liquid composition, e.g.,
peroxidases or oxidases such as laccases, can be used herein. Suitable peroxidases
herein include those of plant, bacterial or fungal origin. Chemically or genetically
modified mutants are included. Examples of suitable peroxidases are those derived
from a strain of Coprinus, e.g., C. cinerius or C. macrorhizus, or from a strain of
Bacillus, e.g., B. pumilus, particularly peroxidase according to
WO 91/05858. Suitable laccases herein include those of bacterial or fungal origin. Chemically
or genetically modified mutants are included. Examples of suitable laccases are those
obtainable from a strain of Trametes, e.g., T. villosa or T. versicolor, or from a
strain of Coprinus, e.g., C. cinereus, or from a strain of Myceliophthora, e.g., M.
thermophila.
[0015] Preferred oxidoreductases in the context of the invention are peroxidases (EC 1.11.1),
laccases (EC 1.10.3.2) and glucose oxidases (EC 1.1.3.4)]. An Example of a commercially
available, oxidoreductase is Gluzyme™ (enzyme available from Novozymes A/S). Further
oxidoreductases are available from other suppliers. Preferred transferases are transferases
in any of the following sub-classes:
- a Transferases transferring one-carbon groups (EC 2.1);
- b transferases transferring aldehyde or ketone residues (EC 2.2); acyltransferases
(EC 2.3);
- c glycosyltransferases (EC 2.4);
- d transferases transferring alkyl or aryl groups, other that methyl groups (EC 2.5);
and
- e transferases-transfering nitrogeneous groups (EC 2.6).
The Composition
[0016] The composition may be any composition, but particularly suitable composition are
cleaning compositions, personal care compositions, textile processing compositions
e.g. bleaching, pharmaceutical compositions, leather processing compositions, pulp
or paper processing compositions, food and beverage compositions and animal feed compositions.
In a particular embodiment of the present invention the liquid composition is a liquid
detergent, eg, laundry detergent or dishwashing detergent. In a more particular embodiment
of the present invention the composition comprises a surfactant
The invention is further directed to the use of the liquid enzyme additive in liquid
detergent composition.
The liquid composition may be a concentrated product to be added to liquid detergents.
The amount of enzyme used in the liquid composition is thus very high. In a particular
embodiment of the present invention the amount of enzyme present in the liquid composition
is at least 1.5 g/L In a more particular embodiment of the present invention the amount
of enzyme is at least 5 g/L. In an even more particular embodiment of the present
invention the amount of enzyme present is at least 10 g/L. In a most particular embodiment
of the present invention the amount of enzyme present is at least 20 g/L such as even
above 25 g/L. In a particular embodiment the amount of enzyme does not exceed 200
g/L. In a more particular embodiment of the present invention the amount of enzyme
does not exceed 150 g/L. In a most particular embodiment of the present invention
the amount of enzyme present in the liquid composition is less than 100 g/L.
In a particular embodiment of the present invention the liquid composition has a pH
of more than 7.5 In a more particular embodiment the pH of the liquid composition
is at least 7 7. ln a most particular embodiment the pH of the liquid composition
is at least 8.0.
In a most particular embodiment of the present invention the liquid composition contain
one or more detergent builders. In a particular embodiment of the present invention
the liquid composition comprises at least 1% w/w of detergent builders. In a more
particular embodiment of the present invention the liquid composition comprises at
least 2% w/w of detergent builders. In a most particular embodiment of the present
invention the liquid composition comprises at least 5% w/w of detergent builders.
[0017] The present Invention is further described by the following examples which should
not be construed as limiting the scope of the invention.
Detergent compositions
[0018] In a particular embodiment of the present invention the liquid composition is a liquid
detergent composition. In a more particular embodiment of the present invention the
liquid composition is a liquid detergent composition for dishwashing or for laundry.
[0019] The detergent composition of the invention may for example be formulated as a hand
or machine laundry detergent composition including a laundry additive composition
suitable for pretreatment of stained fabrics and a rinse added fabric softener composition,
or be formulated as a detergent composition for use in general household hard surface
cleaning operations, or be formulated for hand or machine dishwashing operations.
[0020] Examples of subtilisins are, those derived from
Bacillus, e.g., subtilisin Novo, subtilisin Carlsberg, subtilisin 309, subtilisin 147 and subtilisin
168 (described in
WO 89/06279).
Examples of useful are the variants described in
WO 92/19729,
WO 98/20115, and
WO 98/20116.
Preferred commercially available subtilisins include Alcalase™, Savinase™, Primase™,
Duralase™, Esperase™, and Kannase™ (Novozymes A/S), Maxatase™, Maxacal™, Maxapem™,
Properase™, Purafect™, Purafect OxP™, FN2™, and FN3™ (Genencor International Inc.).
Lipases: Suitable lipases include those of bacterial or fungal origin. Chemically modified
or protein engineered mutants are included. Example of useful lipases include lipases
from
Humicola (synonym
Thermomyces), e.g. from
H. lanuginosa (
T. lanuginasus) as described in
EP 258 068 and
EP 305 216 or from
H. insolens as described in
WO 96/13580, a
Pseudomonas lipase. e.g. from
P. alcaligenes or
P. pseudoalcaligenes (
EP 218 272),
P.
cepacia (
EP 331 376),
P. stutzeri (
GB 1,372,034),
P. fluorescens, Pseudomonas sp. strain SD 705 (
WO 95/06720 and
WO 96/27002),
P. wisconsinensis (
WO 96/12012), a
Bacillus lipase, e.g. from
B.
subtilis (
Dartols et al. (1993), Biochemica et Blophysica Acta, 1131, 253-360),
B. stearothermophilus (
JP 64/744992) or
B. pumilus (
WO 91/16422).
Other examples are lipase variants such as those described in
WO 92/05249,
WO 94/01541.
EP 407 225,
EP 260 105,
WO 95/35381.
WO 96/00292,
WO 95/30744,
WO 94/25578,
WO 95/14783,
WO 95/22615,
WO 97/04079 and
WO 97/07202.
Preferred commercially available lipase enzymes include Lipolase
™ and Lipolase Ultra
™ (Novozymes A/S).
Amylases: Suitable amylases (α and/or β) include those of bacterial or fungal origin. Chemically
modified or protein engineered mutants are included. Amylases include, for example,
α-amylases obtained from
Bacillus, e.g. a special strain of
B. licheniformis, described in more detail in
GB 1,296,839.
Examples of useful amylases are the variants described in
WO 94/02597,
WO 94/18314,
WO 96/23873, and
WO 97/43424.
Commercially available amylases are Duramyl
™, Termamyl
™, Fungamyl
™ and BAN
™ (Novozymes A/S). Rapidase
™ and Purastar
™ (from Genencor International Inc.).
Cellulases: Suitable cellulases include those of bacterial or fungal origin. Chemically modified
or protein engineered mutants are included. Suitable cellulases include cellulases
from the genera
Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, e.g. the fungal cellulases produced from
Humicola lnsolens, Myceliophthora thermophila and
Fusarium oxysporum disclosed in
US 4,435,307,
US 5,648,263,
US 5,691,178,
US 5,776,757 and
WO 89/09259.
Especially suitable cellulases are the alkaline or neutral cellulases having colour
care benefits. Examples of such cellulases are cellulases described in
EP 0 495 257,
EP 0 531 372,
WO 96/11262,
WO 96/29397,
WO 98108940. Other examples are cellulase variants such as those described in
WO 94/07998,
EP 0 531 315,
US 5,457,046,
US 5,686,593,
US 5,763,254,
WO 95/24471,
WO 98/12307 and
PCT/DK98/00299.
Commercially available cellulases include Celluzyme™, and Carezyme™ (Novozymes A/S),
Clazinase™, and Puradax HA™ (Genencor International Inc.), and KAC-500(B)™ (Kao Corporation).
Peroxidases/Oxidases: Suitable peroxidases/oxidases include those of plant, bacterial or fungal origin.
Chemically modified or protein engineered mutants are included. Examples of useful
peroxidases include peroxidases from
Coprinus, e.g from
C.
cinereus, and variants thereof as those described in
WO 93/24618,
WO 95/10602, and
WO 98/15257.
Commercially available peroxidases include Guardzyme™ (Novozymes A/S).
[0021] The detergent enzyme(s) may be included in a detergent composition by adding separate
additives containing one or more enzymes, or by adding a combined additive comprising
all of these enzymes. A liquid detergent may be aqueous, typically containing up to
70% water and 0-30 % organic solvent, or non-aqueous.
The detergent composition comprises one or more surfactants, which may be non-ionic
including semi-polar and/or anionic and/or cationic and/or zwitterionic. The surfactants
are typically present at a level of from 0.1% to 60% by weight.
When included therein the detergent will usually contain from about 1 % to about 40%
of an anionic surfactant such as linear alkylbenzenesulfonate, alpha-olefinsulfonate,
alkyl sulfate (fatty alcohol sulfate), alcohol ethoxysulfate, secondary alkanesulfonate,
alpha-sulfo fatty acid methyl ester, alkyl- or alkenylsuccinic acid or soap.
When included therein the detergent will usually contain from about 0.2% to about
40% of a non-ionic surfactant such as alcohol ethoxylate, nonylphenol ethoxylate,
alkylpolyglycoside, alkyldimethylamineoxide, ethoxylated fatty acid monoethanolamide,
fatty acid monoethanolamide, polyhydroxy alkyl fatty add amide, or N-acyl N-alkyl
derivatives of glucosamine ("glucamides"). The detergent may contain 0-65 % of a detergent
builder or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate,
carbonate, citrate, nitrilotriacetic add, ethylenediaminetetraacetic acid, diethylenetriaminepentaacetic
acid, alkyl- or alkenylsuccinic add, soluble silicates or layered silicates (e.g.
SKS-6 from Hoechst).
The detergent may comprise one or more polymers. Examples are carboxymethylcellulose,
poly(vinylpyrrolidone), poly (ethylene glycol), poly(vinyl alcohol), poly(vinylpyridine-N-oxide),
poly(vinylimidazole), polycarboxylates such as polyacrylates, maleic/acrylic acid
copolymers and lauryl methacrylate/acrylic add copolymers.
The detergent may contain a bleaching system which may comprise a H
2O
2 source such as perborate or percarbonate which may be combined with a peracid-forming
bleach activator such as tetraacetylethylenediamine or nonanoyloxybenzenesulfonate.
Alternatively, the bleaching system may comprise peroxyacids of e g the amide, imide,
or sulfone type.
The detergent may also contain other conventional detergent ingredients such as e.g.
fabric conditioners including clays, foam boosters, suds suppressors, anti-corrosion
agents, soil-suspending agents, anti-soil redeposition agents, dyes, bactericides,
optical brighteners, hydrotropes, tarnish inhibitors, or perfumes.
EXAMPLES
Example 1
[0022] The inhibition constant K
i = [E][I]/[EI] for the inhibition of Savinase was determined using standard methods
under the following conditions:
Substrate: Succinyl-Alanine-Alanine-Proline-para-nitro-anilide = SAAPFpNA (Sigma S-7388).
Buffer: 0.1 M phosphate buffer pH 7.5
Temperature: 25°C
Enzyme concentration in assay ≈ 1 x 10-8 M
The initial rate of substrate hydrolysis was determined with and without inhibitor
at nine substrate concentrations in the range of 0.01 mM to 2 mM using an automated
spectrophotometer.
The inhibition constant K
i was determined using Sigma Plot 9.0, Enzyme Kinetics Module 1.1
| Inhibitor |
K |
| Benzoic Acid |
22 mM |
| Phenylacetic acid |
10 mM |
| Phenylpropionic acid |
9 mM |
| 3,5-dichorobenzoic acid |
2 mM |
| 4-formylbenzoic acid |
25 mM |
| Terephtalic acid (4-carboxybenzoic acid) |
99 mM |
Example 2
[0023] The inhibition constant K
i = [E][I]/[EI] for the inhibition of Savinase was determined using standard methods
under the following conditions:
Substrate: Succinyl-Alanine-Alanine-Proline-para-nitro-anilide = SAAPFpNA (Sigma S-7388).
Buffer: 0.1 M phosphate buffer pH 7.5
Temperature: 25°C
Enzyme concentration in assay ≈ 1 x 10-8 M
The initial rate of substrate hydrolysis was determined with and without inhibitor
at nine substrate concentrations in the range of 0.01 mM to 2 mM using an automated
spectrophotometer.
[0024] The inhibition constant K
i was determined using Sigma Plot 9.0, Enzyme Kinetics Module 1.1
Acids:
[0025]
| Inhibitor |
Ki |
| 3-chlorobenzoic acid |
4 mM |
| 4-chlorobenzoic acid |
5 mM |
| 3-(3-chlorophenyl)propionic acid |
5 mM |
| 3-chlorophenylacetic acid |
7 mM |
| 3-(4-chlorophenyl)propionic acid |
10 mM |
| 4-chlorophenylacetic acid |
11 mM |
| 2-chlorophenylacetic acid |
11 mM |
| 2-chlorobenzoic acid |
16 mM |
| 2-aminobenzoic acid |
16 mM |
| 3-aminobenzoic acid |
43 mM |
| 4-aminobenzoic acid |
82 mM |
| 3-bromobenzoic acid |
6 mM |
| 3-iodobenzoic acid |
9 mM |
| 3-nitrobenzoic acid |
9 mM |
| 3-fluorobenzoic acid |
17 mM |
| 3-formylbenzoic acid |
27 mM |
| 3-(chloromethyl)benzoic acid |
32 mM |
| 3,5-dihydroxybenzoic acid |
76 mM |
| 3-hydroxybenzoic acid |
29 mM |
| 4-phenylbutyric acid |
19 mM |
Example 3 (Reference)
[0026] The inhibition constant K
i = [E][I]/[EI] for the inhibition of Savinase was determined using standard methods
under the following conditions:
Substrate: Succinyl-Alanine-Alanine-Proline-para-nitro-anilide = SAAPFpNA (Sigma S-7388).
Buffer: 0.1 M phosphate buffer pH 7.5
Temperature: 25°C
Enzyme concentration in assay ≈ 1 x 10-8 M
The initial rate of substrate hydrolysis was determined with and without inhibitor
at nine substrate concentrations in the range of 0.01 mM to 2 mM using an automated
spectrophotometer.
The inhibition constant K
i was determined using Sigma Plot 9.0, Enzyme Kinetics Module 1.1
Aldehydes tested:
[0027]
| Inhibitor |
Ki |
| 3-hydroxybenzaldehyde |
16 mM |
| 3,4-dihydrozybenzaldehyde |
11 mM |